Showing posts with label and Zyprexa. Show all posts
Showing posts with label and Zyprexa. Show all posts

Friday, March 16, 2007

Blog Props

Here's a handful of props to some good posts written in the recent past. Enjoy.

  • The Daubert challenge is dissected at the AHRP blog. Any time a legal challenge is based on "expert consensus" in a field, one should be afraid, since we all know that expert consensus tends to dovetail oh-so-nicely with the Big Pharma party line.
  • AHRP also slams what appears to be the overprescription of psych meds for children in foster care.
  • Philip Dawdy has taken the lead on pointing out that the great state of Montana is accusing Lilly of doing some pretty bad things in its promotion of Zyprexa.
  • Brandweek NRX notes that a Lilly spokesperson named Marni Lemons is attempting to make "lemonade" out of the Zyprexa situation (an apt analogy), and that she has proven her acting mettle in a venue outside of her professional role.
  • Health Care Renewal takes a couple of shots at the University of California system for poor use of resources as well as corruption.
  • The Great Beaver Controversy continues -- starting with John Mack, then moving to PharmaGiles and PharmaGossip (here and here).
  • Pharmalot indicates that the Supreme Court may review the practice of Big Pharma paying off generic manufacturers to not introduce generic competitors to the market. Back story here and here.
  • Seroxat Secrets raises some questions about Alastair Benbow and the Big Lies about Paxil/Seroxat.

Friday, March 02, 2007

Dawdy on Australian Radio

Philip Dawdy of the wonderful Furious Seasons blog will be featured on the Australia Radio National network on the All in the Mind program. It is due to air at 10 PM EST -- it can be streamed live here. He'll be talking about the Zyprexa debacle, on which he has written extensively on his site. I have written about similar topics. Mr. Dawdy is also hosting the Zyprexa documents, which have likely been downloaded by hundreds, if not thousands of individuals worldwide, likely much to Lilly's chagrin.

I'm certain that his appearance on Aussie radio is going to be well worth a listen. Check it out. It will also be rebroadcast on Sunday at the same time, and I assume it will also be archived on the broadcaster's site at some point in the near future. I also cannot wait to hear what Lilly has to say in its defense, as one of their spokespersons is apparently going to appear on the show as well.

Friday, February 09, 2007

Zyprexa Editorial

No, not my editorial. I think my views on this have already been made clear. Courtesy of Health Care Renewal, an excellent editorial from Richard Zitrin is reproduced and Roy Poses' excellent commentary follows, which includes the following:
So let's see, continuing news stories and commentaries suggest Eli Lilly has been trying to hide unfavorable information about its blockbuster drug Zyprexa, the company's share price is falling, and yet its top executives are getting large increases in their already lavish compensation.
Good point (as usual), Roy. Read the whole piece. It's got secrecy, executive compensation, lawyers, Lilly, and Zyprexa all in the same post. You can't top that.